Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,693 | -2,133 | -1,179 | -12,775 | -11,605 |
| Depreciation Amortization | 9,264 | 15 | 7 | 3,311 | 3,303 |
| Income taxes - deferred | -2,919 | N/A | N/A | N/A | N/A |
| Other Working Capital | -210 | -317 | 6 | -882 | -244 |
| Other Operating Activity | 245 | 134 | 166 | 3,946 | 3,823 |
| Operating Cash Flow | $-3,314 | $-2,302 | $-1,001 | $-6,399 | $-4,722 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 2 | 2 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $2 | $2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 16,127 | 16,126 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $16,127 | $16,126 |
| Beginning Cash Position | 10,368 | 10,368 | 10,368 | 638 | 638 |
| End Cash Position | 7,054 | 8,067 | 9,367 | 10,368 | 12,045 |
| Net Cash Flow | $-3,314 | $-2,302 | $-1,001 | $9,730 | $11,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,314 | -2,302 | -1,001 | -6,399 | -4,722 |
| Free Cash Flow | -3,314 | -2,302 | -1,001 | -6,399 | -4,722 |